Sign In
Buy MRNA
$49.06
+3.42 (+7.49%)
At Close: Jun 03, 2026
Moderna's $54M Lifeline: Bird Flu Bet Revived After U.S. Pullback
12:32pm, Thursday, 18'th Dec 2025
Funding support from outside groups could be opening a new chapter for Moderna (MRNA) as the company advances its bird flu vaccine program amid a shifting US re
Moderna secures up to $54.3 million funding for bird flu vaccine from global coalition
07:02am, Thursday, 18'th Dec 2025
Moderna will get up to $54.3 million in funding from a global coalition to support late-stage development of its experimental bird flu vaccine, the U.S. drugmaker said on Thursday.
CEPI to Fund Pivotal Phase 3 Trial for Moderna's mRNA Pandemic Influenza Vaccine Candidate
07:00am, Thursday, 18'th Dec 2025
Up to $54.3 million CEPI investment aims to help advance Moderna's H5 pandemic influenza vaccine candidate to licensure Partnership strengthens global preparedness against a significant pandemic threa
Moderna to Present at the 44th Annual J.P. Morgan Healthcare Conference
07:00am, Wednesday, 17'th Dec 2025
CAMBRIDGE, MA / ACCESS Newswire / December 17, 2025 / Moderna, Inc. (Nasdaq:MRNA) today announced it will present at the 44th annual J.P. Morgan Healthcare Conference on Monday, January 12th at 7:30 p
CHMP Backs EU Approval of MRNA's New COVID-19 Vaccine mNexspike
10:56am, Tuesday, 16'th Dec 2025
CHMP backs EU approval of Moderna's next-generation mNexspike COVID-19 vaccine, with a final European Commission decision expected shortly.
mNEXSPIKE is Moderna's third product to receive a positive CHMP opinion alongside Spikevax (COVID-19 Vaccine, mRNA) and mRESVIA (Respiratory Syncytial Virus Vaccine) mNEXSPIKE will be available in the
Market Today: Tech Slumps, Broadcom Tanks; EU Eases ICE Ban
05:35pm, Friday, 12'th Dec 2025
Stock News Tech-led selloff caps tough week: US stocks fell as investors rotated out of mega-cap tech after Broadcom (AVGO) and Oracle (ORCL) stoked AI-spending
FDA Weighs Black Box Warning For COVID Vaccines, Experts Push Back
01:51pm, Friday, 12'th Dec 2025
FDA officials are weighing a black box warning for Covid vaccines, a proposal that has drawn strong criticism from outside experts citing lack of evidence.
Moderna 2026 Covid and RSV growth not enough to boost stock, Jefferies says
11:42am, Friday, 12'th Dec 2025
Moderna Inc (NASDAQ:MRNA, XETRA:0QF) has been awarded a ‘Hold' rating and $30 price target, implying limited upside, from Jefferies analysts in their initial coverage of the drugmaker. Moderna share
Pre-Market Stock Futures: The futures are trading mixed as we get set to close out a wild and woolly week that saw a touch of just about everything. The Federal Reserve, as expected, cut rates again a
Moderna 2026 Covid and RSV growth not enough to boost stock, Jefferies says
06:39am, Friday, 12'th Dec 2025
Moderna Inc (NASDAQ:MRNA, XETRA:0QF) has been awarded a ‘Hold’ rating and $30 price target, implying limited upside, from Jefferies analysts in their...
U.S. Global Investors to continue monthly dividends; highlights strong performance of gold, silver and airline sector
06:03am, Friday, 12'th Dec 2025
U.S. Global Investors (NASDAQ:GROW) announced that it will maintain its monthly dividend payments, with $0.0075 per share scheduled for January through...
Roivant Signals Major Pipeline Momentum With Accelerated Timelines
01:39pm, Thursday, 11'th Dec 2025
Roivant (NASDAQ: ROIV) outlined accelerated timelines and expanded commercial ambitions for several late-stage programs.
Amundi Sells 425,861 Shares of Moderna, Inc. $MRNA
03:25am, Wednesday, 10'th Dec 2025
Amundi reduced its position in shares of Moderna, Inc. (NASDAQ: MRNA) by 31.9% during the undefined quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The fi
Moderna (MRNA) Recently Broke Out Above the 50-Day Moving Average
10:31am, Monday, 08'th Dec 2025
Moderna (MRNA) reached a significant support level, and could be a good pick for investors from a technical perspective. Recently, MRNA broke through the 50-day moving average, which suggests a short-
